Reuters -- Pfizer (PFE.N) has said it will conduct more research on Asian populations in coming years to design drugs for diseases prevalent in the region, such as cancers of the liver and head and neck.
Reuters -- Pfizer (PFE.N) has said it will conduct more research on Asian populations in coming years to design drugs for diseases prevalent in the region, such as cancers of the liver and head and neck.
